# PicoCELA Inc.: financial statements, quarterly

PCLA · Nasdaq · CIK 2018462 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/pcla.md) · [Financials](/companies/pcla/financials.md) · [Filings](/companies/pcla/filings.md) · [Insiders](/companies/pcla/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pcla/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2021-09-30) | period not labelled (2022-09-30) | period not labelled (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [428](/filings/0001493152-25-006944.md) | [457](/filings/0001493152-26-006698.md) | [535](/filings/0001493152-26-006698.md) |
| Current assets | $m | not reported | not reported | [1,011](/filings/0001493152-25-006944.md) | [947](/filings/0001493152-26-006698.md) | [992](/filings/0001493152-26-006698.md) |
| Total assets | $m | not reported | not reported | [1,149](/filings/0001493152-25-006944.md) | [1,235](/filings/0001493152-26-006698.md) | [1,087](/filings/0001493152-26-006698.md) |
| Current liabilities | $m | not reported | not reported | [367](/filings/0001493152-25-006944.md) | [435](/filings/0001493152-26-006698.md) | [465](/filings/0001493152-26-006698.md) |
| Total liabilities | $m | not reported | not reported | [453](/filings/0001493152-25-006944.md) | [880](/filings/0001493152-26-006698.md) | [617](/filings/0001493152-26-006698.md) |
| Long-term debt | $m | not reported | not reported | [26.3](/filings/0001493152-25-006944.md) | [28.3](/filings/0001493152-26-006698.md) | [10.4](/filings/0001493152-26-006698.md) |
| Current portion of debt | $m | not reported | not reported | [215](/filings/0001493152-25-006944.md) | [218](/filings/0001493152-26-006698.md) | [262](/filings/0001493152-26-006698.md) |
| Short-term borrowings | $m | not reported | not reported | [215](/filings/0001493152-25-006944.md) | [218](/filings/0001493152-26-006698.md) | [262](/filings/0001493152-26-006698.md) |
| Shareholders' equity | $m | [473](/filings/0001493152-25-006944.md) | [468](/filings/0001493152-26-006698.md) | [696](/filings/0001493152-26-006698.md) | [355](/filings/0001493152-26-006698.md) | [470](/filings/0001493152-26-006698.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 1,153,806 at 2025-09-30, from the cover of the [20-F filed 2026-02-13](/filings/0001493152-26-006698.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.